Catalyst Wire Dossier Catalyst Wire Dossier

Hyaluronate injectable viscosupplement

· Actavis Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hyaluronate injectable viscosupplement, covering 2020-06-23 to 2020-06-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee [NA]

See pricing